Carregant...
Immunotherapy for hepatocellular carcinoma: current status and future perspectives
The discovery of the immune checkpoint mechanism has contributed greatly to recent advances in cancer treatment. The anticytotoxic T lymphocyte-associated protein 4 antibody ipilimumab was first approved as a therapeutic drug for malignant melanoma in the USA in 2011; since then, antiprogrammed cell...
Guardat en:
| Publicat a: | ESMO Open |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6307608/ https://ncbi.nlm.nih.gov/pubmed/30622744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2018-000455 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|